DECITABIN Accord subst seche 50 mg 1 pce
7680682550012
CH-68255
L01BC08
07.16.1.
Active substances:
1 / 3
google
Details
- Product number
- 6825501
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- decitabinum 50 mg, kalii dihydrogenophosphas corresp. kalium 19.53 mg, natrii hydroxidum corresp. natrium 6.67 mg, pro vitro.
Articles (1)
Decitabin Accord 50 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
decitabinum
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
kalii dihydrogenophosphas
|
- | Substance | HNIDK |
|
kalium
|
19.53 MG | Substance | HBESI |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
natrium
|
6.67 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 886.30
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/01/2023
Authorization holder
Accord Healthcare AG
4103 Bottmingen
Authorization information
- Swissmedic authorization number
- 68255
- Drug name
- Decitabin Accord, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPI
- ATC Code
- L01BC08
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 19/10/2022
- Authorization expiration date
- 18/10/2027
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DECITABIN Accord subst seche 50 mg 1 pce
- Description (DE)
- DECITABIN Accord Trockensub 50 mg 1 Stk
- Market launch
- 19/10/2022
- Narcotic (BTM)
- No
Original drug
Dacogen, Lyophilisat zur Herstellung eines Konzentrats zur Herstellung einer Infusionslösung
GTIN:
7680624060012
CHF 968.35